Pharma Journalist -

The U.S. Food and Drug Administration approved the first generic version of Sabril (vigabatrin) 500 mg tablets for treating complex partial seizures, also called focal seizures, as an…
Read More...

Abbott announced that it has exercised its option to purchase Cephea Valve Technologies, Inc., a privately held medical device company developing a less-invasive heart valve replacement…
Read More...

SMi Group are delighted to have industry expert Tom Parke to lead the post-conference workshop during Adaptive Designs in Clinical Trials 2019. The 11th Annual Adaptive Designs in…
Read More...

SMi reports: Registration will close in less than week, as the countdown begins for the 8th Annual Pharmaceutical Microbiology UK Conference. The 8th Annual Pharmaceutical…
Read More...

Silence Therapeutics announces that its lead medicine candidate SLN124 has been granted Orphan Drug Designation by the Committee for Orphan Medicinal Products (COMP), the European…
Read More...

Cobra Biologics announced the appointment of Dr Darrell Sleep as Director of Innovation. The appointment is part of on-going strategic expansion activities currently underway at Cobra’s…
Read More...

Exelixis announced that the U.S. Food and Drug Administration (FDA) approved CABOMETYX (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been previously…
Read More...

Key Pharmaceuticals Ltd to lead a workshop on Parallel Trade & Brexit during the 13th Annual Parallel Trade Conference SMi Group are delighted to have industry expert Tushar…
Read More...

Puma Biotechnology announced that it has entered into an exclusive License Agreement with Knight Therapeutics Inc. that grants Knight the exclusive right to commercialize NERLYNX…
Read More...

As China continues to advance from a big country in pharmaceuticals to a power in pharmaceuticals, and the global economy maintains good trends, the main business income of API…
Read More...